Recent clinical evidence demonstrates that adjuvant radiotherapy significantly improves patient outcomes for aggressive brain malignancies following surgical intervention. Since recurrence rates approach 50% in untreated cases, post-operative radiation therapy represents a critical treatment strategy. This therapeutic approach targets residual cancer cells and microscopic disease, substantially reducing the likelihood of tumor progression. Understanding the role of combined modality treatment helps oncologists develop personalized protocols that enhance survival rates and quality of life for brain cancer patients.

Summary auto-generated by AI from the original publisher's content. Editorial standards.